(Q42869176)

English

hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy

scientific article published on 5 October 2010

Statements

hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy (English)
Eran Elyakim
Einat Sitbon
Alexander Faerman
Sarit Tabak
Eve Montia
Liron Belanis
Avital Dov
Eric G Marcusson
C Frank Bennett
Ayelet Chajut
Dalia Cohen
Noga Yerushalmi
5 October 2010
8077-8087

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit